{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:13:56Z","timestamp":1791360836011,"version":"4.3.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00345-019-02678-x","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T13:14:43Z","timestamp":1550063683000},"page":"2419-2427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study"],"prefix":"10.1007","volume":"37","author":[{"given":"Ahmet M.","family":"Aydin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Panwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon L.","family":"Woldu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Freifeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon Z.","family":"Weizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"Remzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Rioux-Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Haitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roscigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bolenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Bensalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Westerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur I.","family":"Sagalowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Bagrodia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5837-4561","authenticated-orcid":false,"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura-Maria","family":"Krabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"issue":"1","key":"2678_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupret","year":"2018","unstructured":"Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, Palou J, Shariat SF (2018) European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73(1):111\u2013122. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2017.07.036","journal-title":"Eur Urol"},{"issue":"6","key":"2678_CR2","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","volume":"54","author":"M Roupret","year":"2008","unstructured":"Roupret M, Yates DR, Comperat E, Cussenot O (2008) Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol 54(6):1226\u20131236. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2008.08.008","journal-title":"Eur Urol"},{"issue":"6","key":"2678_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG, Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma C (2009) Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115(6):1224\u20131233. \n                    https:\/\/doi.org\/10.1002\/cncr.24135","journal-title":"Cancer"},{"issue":"12","key":"2678_CR4","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/cncr.28655","volume":"120","author":"S Porten","year":"2014","unstructured":"Porten S, Siefker-Radtke AO, Xiao L, Margulis V, Kamat AM, Wood CG, Jonasch E, Dinney CP, Matin SF (2014) Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer 120(12):1794\u20131799. \n                    https:\/\/doi.org\/10.1002\/cncr.28655","journal-title":"Cancer"},{"issue":"8","key":"2678_CR5","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1200\/JCO.2016.69.4141","volume":"35","author":"T Seisen","year":"2017","unstructured":"Seisen T, Krasnow RE, Bellmunt J, Roupret M, Leow JJ, Lipsitz SR, Vetterlein MW, Preston MA, Hanna N, Kibel AS, Sun M, Choueiri TK, Trinh QD, Chang SL (2017) Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma. J Clin Oncol 35(8):852\u2013860. \n                    https:\/\/doi.org\/10.1200\/JCO.2016.69.4141","journal-title":"J Clin Oncol"},{"issue":"5","key":"2678_CR6","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","volume":"164","author":"JJ Munoz","year":"2000","unstructured":"Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164(5):1523\u20131525","journal-title":"J Urol"},{"issue":"9","key":"2678_CR7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","volume":"16","author":"DE Jensen","year":"1998","unstructured":"Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher FJ 3rd (1998) BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16(9):1097\u20131112","journal-title":"Oncogene"},{"issue":"Spec No 1","key":"2678_CR8","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1093\/hmg\/ddg082","volume":"12","author":"CX Deng","year":"2003","unstructured":"Deng CX, Wang RH. Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum Mol Genet. 2003;12(Spec No 1):R113\u201323.","journal-title":"Hum Mol Genet"},{"issue":"17","key":"2678_CR9","doi-asserted-by":"publisher","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","volume":"68","author":"KH Ventii","year":"2008","unstructured":"Ventii KH, Devi NS, Friedrich KL, Chernova TA, Tighiouart M, Van Meir EG, Wilkinson KD (2008) BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res 68(17):6953\u20136962. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0365","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"2678_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12013-011-9184-6","volume":"60","author":"ZM Eletr","year":"2011","unstructured":"Eletr ZM, Wilkinson KD (2011) An emerging model for BAP1's role in regulating cell cycle progression. Cell Biochem Biophys 60(1\u20132):3\u201311. \n                    https:\/\/doi.org\/10.1007\/s12013-011-9184-6","journal-title":"Cell Biochem Biophys"},{"issue":"6","key":"2678_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1097\/PAS.0000000000000645","volume":"40","author":"JA Nes van de","year":"2016","unstructured":"van de Nes JA, Nelles J, Kreis S, Metz CH, Hager T, Lohmann DR, Zeschnigk M (2016) Comparing the prognostic value of BAP1 mutation pattern, chromosome 3 status, and BAP1 immunohistochemistry in uveal melanoma. Am J Surg Pathol 40(6):796\u2013805. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000000645","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2678_CR12","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/cncr.28521","volume":"120","author":"RW Joseph","year":"2014","unstructured":"Joseph RW, Kapur P, Serie DJ, Eckel-Passow JE, Parasramka M, Ho T, Cheville JC, Frenkel E, Rakheja D, Brugarolas J, Parker A (2014) Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma. Cancer 120(7):1059\u20131067. \n                    https:\/\/doi.org\/10.1002\/cncr.28521","journal-title":"Cancer"},{"issue":"11","key":"2678_CR13","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.jtho.2016.06.020","volume":"11","author":"L Righi","year":"2016","unstructured":"Righi L, Duregon E, Vatrano S, Izzo S, Giorcelli J, Rondon-Lagos M, Ascoli V, Ruffini E, Ventura L, Volante M, Papotti M, Scagliotti GV (2016) BRCA1-associated protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: a large retrospective study. J Thorac Oncol 11(11):2006\u20132017. \n                    https:\/\/doi.org\/10.1016\/j.jtho.2016.06.020","journal-title":"J Thorac Oncol"},{"issue":"54","key":"2678_CR14","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1038\/sj.onc.1206964","volume":"22","author":"JW Catto","year":"2003","unstructured":"Catto JW, Azzouzi AR, Amira N, Rehman I, Feeley KM, Cross SS, Fromont G, Sibony M, Hamdy FC, Cussenot O, Meuth M (2003) Distinct patterns of microsatellite instability are seen in tumours of the urinary tract. Oncogene 22(54):8699\u20138706. \n                    https:\/\/doi.org\/10.1038\/sj.onc.1206964","journal-title":"Oncogene"},{"issue":"5","key":"2678_CR15","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.juro.2014.11.007","volume":"193","author":"LM Krabbe","year":"2015","unstructured":"Krabbe LM, Bagrodia A, Haddad AQ, Kapur P, Khalil D, Hynan LS, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V (2015) Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract. J Urol 193(5):1486\u20131493. \n                    https:\/\/doi.org\/10.1016\/j.juro.2014.11.007","journal-title":"J Urol"},{"key":"2678_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-88441-7","volume-title":"Cancer staging manual","author":"AJCC American Joint Committee on Cancer","year":"2010","unstructured":"AJCC American Joint Committee on Cancer (2010) Cancer staging manual, 7th edn. Springer, New York","edition":"7"},{"issue":"12","key":"2678_CR17","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","volume":"22","author":"JI Epstein","year":"1998","unstructured":"Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol. 1998;22(12):1435\u201348.","journal-title":"Am J Surg Pathol"},{"key":"2678_CR18","unstructured":"Hintze J (2011) PASS 11. NCSS, LLC, Kaysville. \n                    http:\/\/www.ncss.com"},{"issue":"10","key":"2678_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/gcc.22381","volume":"55","author":"C Luchini","year":"2016","unstructured":"Luchini C, Veronese N, Yachida S, Cheng L, Nottegar A, Stubbs B, Solmi M, Capelli P, Pea A, Barbareschi M, Fassan M, Wood LD, Scarpa A (2016) Different prognostic roles of tumor suppressor gene BAP1 in cancer: a systematic review with meta-analysis. Genes Chromosomes Cancer 55(10):741\u2013749. \n                    https:\/\/doi.org\/10.1002\/gcc.22381","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"2678_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.juro.2013.09.041","volume":"191","author":"P Kapur","year":"2014","unstructured":"Kapur P, Christie A, Raman JD, Then MT, Nuhn P, Buchner A, Bastian P, Seitz C, Shariat SF, Bensalah K, Rioux-Leclercq N, Xie XJ, Lotan Y, Margulis V, Brugarolas J (2014) BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma. J Urol 191(3):603\u2013610. \n                    https:\/\/doi.org\/10.1016\/j.juro.2013.09.041","journal-title":"J Urol"},{"issue":"2","key":"2678_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1470-2045(12)70584-3","volume":"14","author":"P Kapur","year":"2013","unstructured":"Kapur P, Pena-Llopis S, Christie A, Zhrebker L, Pavia-Jimenez A, Rathmell WK, Xie XJ, Brugarolas J (2013) Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol 14(2):159\u2013167. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(12)70584-3","journal-title":"Lancet Oncol"},{"issue":"4","key":"2678_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/PAT.0000000000000250","volume":"47","author":"M Farzin","year":"2015","unstructured":"Farzin M, Toon CW, Clarkson A, Sioson L, Watson N, Andrici J, Gill AJ (2015) Loss of expression of BAP1 predicts longer survival in mesothelioma. Pathology 47(4):302\u2013307. \n                    https:\/\/doi.org\/10.1097\/PAT.0000000000000250","journal-title":"Pathology"},{"issue":"5","key":"2678_CR23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/his.13127","volume":"70","author":"K Misumi","year":"2017","unstructured":"Misumi K, Hayashi A, Shibahara J, Arita J, Sakamoto Y, Hasegawa K, Kokudo N, Fukayama M (2017) Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss. Histopathology 70(5):766\u2013774. \n                    https:\/\/doi.org\/10.1111\/his.13127","journal-title":"Histopathology"},{"issue":"2","key":"2678_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","volume":"45","author":"R Murali","year":"2013","unstructured":"Murali R, Wiesner T, Scolyer RA (2013) Tumours associated with BAP1 mutations. Pathology 45(2):116\u2013126. \n                    https:\/\/doi.org\/10.1097\/PAT.0b013e32835d0efb","journal-title":"Pathology"},{"issue":"7","key":"2678_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pena-Llopis","year":"2012","unstructured":"Pena-Llopis S, Vega-Rubin-de-Celis S, Liao A, Leng N, Pavia-Jimenez A, Wang S, Yamasaki T, Zhrebker L, Sivanand S, Spence P, Kinch L, Hambuch T, Jain S, Lotan Y, Margulis V, Sagalowsky AI, Summerour PB, Kabbani W, Wong SW, Grishin N, Laurent M, Xie XJ, Haudenschild CD, Ross MT, Bentley DR, Kapur P, Brugarolas J (2012) BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 44(7):751\u2013759. \n                    https:\/\/doi.org\/10.1038\/ng.2323","journal-title":"Nat Genet"},{"issue":"18","key":"2678_CR26","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1158\/1078-0432.CCR-14-0330","volume":"20","author":"ML Nickerson","year":"2014","unstructured":"Nickerson ML, Dancik GM, Im KM, Edwards MG, Turan S, Brown J, Ruiz-Rodriguez C, Owens C, Costello JC, Guo G, Tsang SX, Li Y, Zhou Q, Cai Z, Moore LE, Lucia MS, Dean M, Theodorescu D (2014) Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer. Clin Cancer Res 20(18):4935\u20134948. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0330","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2678_CR27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, Network TR, Weinstein JN, Kwiatkowski DJ, Lerner SP. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2017;171(3):540\u2013556 e525. \n                    https:\/\/doi.org\/10.1016\/j.cell.2017.09.007\n                    \n                  .","journal-title":"Cell"},{"issue":"6","key":"2678_CR28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","volume":"68","author":"JP Sfakianos","year":"2015","unstructured":"Sfakianos JP, Cha EK, Iyer G, Scott SN, Zabor EC, Shah RH, Ren Q, Bagrodia A, Kim PH, Hakimi AA, Ostrovnaya I, Ramirez R, Hanrahan AJ, Desai NB, Sun A, Pinciroli P, Rosenberg JE, Dalbagni G, Schultz N, Bajorin DF, Reuter VE, Berger MF, Bochner BH, Al-Ahmadie HA, Solit DB, Coleman JA (2015) Genomic characterization of upper tract urothelial carcinoma. Eur Urol 68(6):970\u2013977. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2015.07.039","journal-title":"Eur Urol"},{"issue":"4","key":"2678_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","volume":"72","author":"TJ Moss","year":"2017","unstructured":"Moss TJ, Qi Y, Xi L, Peng B, Kim TB, Ezzedine NE, Mosqueda ME, Guo CC, Czerniak BA, Ittmann M, Wheeler DA, Lerner SP, Matin SF (2017) Comprehensive genomic characterization of upper tract urothelial carcinoma. Eur Urol 72(4):641\u2013649. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2017.05.048","journal-title":"Eur Urol"},{"issue":"1","key":"2678_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00428-016-2025-7","volume":"470","author":"ZC Deans","year":"2017","unstructured":"Deans ZC, Costa JL, Cree I, Dequeker E, Edsjo A, Henderson S, Hummel M, Ligtenberg MJ, Loddo M, Machado JC, Marchetti A, Marquis K, Mason J, Normanno N, Rouleau E, Schuuring E, Snelson KM, Thunnissen E, Tops B, Williams G, van Krieken H, Hall JA, ASBL IQNP (2017) Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL. Virchows Arch 470(1):5\u201320. \n                    https:\/\/doi.org\/10.1007\/s00428-016-2025-7","journal-title":"Virchows Arch"},{"issue":"1","key":"2678_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000360227","volume":"94","author":"JY Lee","year":"2015","unstructured":"Lee JY, Cho KS, Diaz RR, Choi YD, Choi HY (2015) p53 expression as a prognostic factor in upper urinary tract urothelial carcinoma: a systematic review and meta-analysis. Urol Int 94(1):50\u201357. \n                    https:\/\/doi.org\/10.1159\/000360227","journal-title":"Urol Int"},{"issue":"7331","key":"2678_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nature09639","volume":"469","author":"I Varela","year":"2011","unstructured":"Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, Davies H, Jones D, Lin ML, Teague J, Bignell G, Butler A, Cho J, Dalgliesh GL, Galappaththige D, Greenman C, Hardy C, Jia M, Latimer C, Lau KW, Marshall J, McLaren S, Menzies A, Mudie L, Stebbings L, Largaespada DA, Wessels LF, Richard S, Kahnoski RJ, Anema J, Tuveson DA, Perez-Mancera PA, Mustonen V, Fischer A, Adams DJ, Rust A, Chan-on W, Subimerb C, Dykema K, Furge K, Campbell PJ, Teh BT, Stratton MR, Futreal PA (2011) Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma. Nature 469(7331):539\u2013542. \n                    https:\/\/doi.org\/10.1038\/nature09639","journal-title":"Nature"},{"issue":"4","key":"2678_CR33","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2214\/AJR.16.16064","volume":"207","author":"Y Mao","year":"2016","unstructured":"Mao Y, Kilcoyne A, Hedgire S, Preston MA, McGovern FJ, Dahl DM, Harisinghani M (2016) Patterns of recurrence in upper tract transitional cell carcinoma: imaging surveillance. AJR Am J Roentgenol 207(4):789\u2013796. \n                    https:\/\/doi.org\/10.2214\/AJR.16.16064","journal-title":"AJR Am J Roentgenol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-02678-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T19:05:24Z","timestamp":1581534324000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-02678-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2678"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-02678-x","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"28 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We declare that there are no potential competing interests in this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted according to the Declaration of Helsinki and institutional review board approval was obtained at each center participating in this research. An institutional IRB was granted through a local ethics committee at each location.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}